TOLEDO, OHIO and ANTWERP, BELGIUM – BUSINESSWIRE—MARCH 27, 2023—NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its acquisition of SUAZIO, an EU-based strategic consultancy providing global market research services to medical device and IVD developers.
Founded in 2001 in Antwerp, Belgium, SUAZIO’s mission is to provide market insights to the MedTech industry across the globe through its data, people and analytics solutions. The organization develops custom frameworks for each Client based on specific market needs, technology value drivers, patient journeys, digital healthcare environment and economic value proposition. Keeping each stakeholder’s perspective in mind, this research results in robust data and accurate interpretation leading to clear recommendations and strategies for successful market introduction.
“NAMSA is very enthusiastic to expand its global strategic consulting services with the addition of SUAZIO,” commented Dr. Christophe Berthoux, NAMSA CEO. “Client insights and precise market research are what power the true value of novel medical technologies and product acceptance. With the SUAZIO Team, NAMSA will expand its Client reach even further and strengthen the delivery of its full continuum development services to the global MedTech industry,” Dr. Berthoux concluded.
NAMSA’s other consulting services include: Biological Safety, Quality, Regulatory, Reimbursement and Product Development Strategy. These teams are led by the MedTech industry’s foremost experts, many of whom have held positions with the U.S. Food and Drug Administration (FDA), EU Notified Bodies and APAC authorities. NAMSA Consultants, who communicate with global government entities daily, are uniquely qualified to provide wide-ranging consulting services across the product development spectrum. NAMSA’s proven services and outcomes ultimately allow Clients to get to market faster and make a more immediate impact on patient safety and global healthcare.
“SUAZIO has sought to extend its reach within the MedTech ecosystem for some time and we could not be more thrilled to join NAMSA in its mission to deliver best-in-class global MedTech solutions through our people, expertise and technology,” stated SUAZIO CEO, Christophe Van der Linden. “With similar values and expertise in providing insights to accelerate MedTech innovation, our services are well-aligned to truly deliver global Clients end-to-end development and commercialization solutions that lead to success.”
The acquisition of SUAZIO increases NAMSA’s global presence to 20 locations across the Americas, Asia and Europe.
The price and terms of the transaction are undisclosed.
Leah Davidson, MA, MBA, PCM
Leah has been with NAMSA since 2016 and currently serves as Senior Manager of Global Marketing Communications. She possesses nearly 25 years' experience within the medical device and healthcare technology industries and has worked in various marketing and communications capacities throughout her career. In her role at NAMSA, she is responsible for the development and implementation of brand strategies and marketing communications initiatives that help drive the organization's sales and organizational growth goals globally.